DocGo Inc. Operating Cash Flow
DocGo Inc. (DCGO) reported Operating Cash Flow of -$13.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-17
- DocGo Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.24M, a 127.15% decline year-over-year.
- DocGo Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.66M, a 150.54% decline year-over-year.
- DocGo Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$10.47M, a 182.30% decline year-over-year.
- DocGo Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $1.66M, a 94.67% decline year-over-year.
- DocGo Inc. net cash provided by (used in) operating activities for fiscal 2025 was $34.45M, a 50.86% decline from fiscal 2024.
- DocGo Inc. net cash provided by (used in) operating activities for fiscal 2024 was $70.12M.
- DocGo Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$64.49M, a 323.39% decline from fiscal 2022.
- DocGo Inc. net cash provided by (used in) operating activities for fiscal 2022 was $28.87M.
| Period end | Net Cash Provided by (Used in) Operating Activities 2 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 5 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$13.90M 10-Q · filed 2026-08-17 | -$24.37M derived: sum of 3 quarters · filed 2026-08-17 | -$22.71M derived: sum of 4 quarters · filed 2026-08-17 | ||||||
| 2026-03-31 | -$4.66M 10-Q · filed 2026-05-11 | -$15.13M derived: sum of 2 quarters · filed 2026-05-11 | -$13.47M derived: sum of 3 quarters · filed 2026-05-11 | $20.58M derived: sum of 4 quarters · filed 2026-08-17 | ||||||
| 2025-12-31 | -$10.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$8.81M derived: sum of 2 quarters · filed 2026-03-16 | $25.23M derived: sum of 3 quarters · filed 2026-08-17 | $34.45M 10-K · filed 2026-03-16 | ||||||
| 2025-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $35.70M derived: sum of 2 quarters · filed 2026-08-17 | $44.92M 10-Q · filed 2025-11-10 | $57.64M derived: sum of 4 quarters · filed 2026-08-17 | ||||||
| 2025-06-30 | $34.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $43.26M 10-Q · filed 2026-08-17 | $55.98M derived: sum of 3 quarters · filed 2026-08-17 | $87.13M derived: sum of 4 quarters · filed 2026-08-17 | ||||||
| 2025-03-31 | $9.22M 10-Q · filed 2026-05-11 | $9.66M 10-Q · filed 2025-05-08 | $21.94M derived: sum of 2 quarters · filed 2026-05-11 | $53.08M derived: sum of 3 quarters · filed 2026-05-11 | $89.97M derived: sum of 4 quarters · filed 2026-05-11 | |||||
| 2024-12-31 | $12.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $43.87M derived: sum of 2 quarters · filed 2026-03-16 | $80.76M derived: sum of 3 quarters · filed 2026-03-16 | $70.12M 10-K · filed 2026-03-16 | $70.34M 10-K · filed 2025-02-27 | |||||
| 2024-09-30 | $31.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $68.04M derived: sum of 2 quarters · filed 2025-11-10 | $57.40M 10-Q · filed 2025-11-10 | $57.45M 10-Q · filed 2024-11-07 | $51.21M derived: sum of 4 quarters · filed 2026-03-16 | |||||
| 2024-06-30 | $36.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $26.25M 10-Q · filed 2025-08-07 | $26.42M 10-Q · filed 2024-08-07 | $20.06M derived: sum of 3 quarters · filed 2026-03-16 | -$25.82M derived: sum of 4 quarters · filed 2026-03-16 | |||||
| 2024-03-31 | -$10.64M 10-Q · filed 2025-05-08 | -$16.83M derived: sum of 2 quarters · filed 2026-03-16 | -$62.71M derived: sum of 3 quarters · filed 2026-03-16 | -$52.01M derived: sum of 4 quarters · filed 2026-03-16 | ||||||
| 2023-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$52.07M derived: sum of 2 quarters · filed 2026-03-16 | -$41.38M derived: sum of 3 quarters · filed 2026-03-16 | -$64.49M 10-K · filed 2026-03-16 | -$64.22M 10-K · filed 2024-02-28 | |||||
| 2023-09-30 | -$45.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$35.19M derived: sum of 2 quarters · filed 2024-11-07 | -$58.30M 10-Q · filed 2024-11-07 | -$67.04M derived: sum of 4 quarters · filed 2025-02-27 | ||||||
| 2023-06-30 | $10.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$12.42M 10-Q · filed 2024-08-07 | -$21.16M derived: sum of 3 quarters · filed 2025-02-27 | -$13.74M derived: sum of 4 quarters · filed 2025-02-27 | ||||||
| 2023-03-31 | -$23.12M 10-Q · filed 2024-05-08 | -$31.86M derived: sum of 2 quarters · filed 2025-02-27 | -$24.44M derived: sum of 3 quarters · filed 2025-02-27 | -$12.51M derived: sum of 4 quarters · filed 2025-02-27 | ||||||
| 2022-12-31 | -$8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.32M derived: sum of 2 quarters · filed 2025-02-27 | $10.61M derived: sum of 3 quarters · filed 2025-02-27 | $28.87M 10-K · filed 2025-02-27 | ||||||
| 2022-09-30 | $7.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $19.34M derived: sum of 2 quarters · filed 2023-11-06 | $37.61M 10-Q · filed 2023-11-06 | $28.81M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-06-30 | $11.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $30.19M 10-Q · filed 2023-08-08 | $21.39M derived: sum of 3 quarters · filed 2024-02-28 | $29.38M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-03-31 | $18.26M 10-Q · filed 2023-05-09 | $9.46M derived: sum of 2 quarters · filed 2024-02-28 | $17.46M derived: sum of 3 quarters · filed 2024-02-28 | $17.70M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2021-12-31 | -$8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$802.03K derived: sum of 2 quarters · filed 2024-02-28 | -$563.25K derived: sum of 3 quarters · filed 2024-02-28 | -$1.95M 10-K · filed 2024-02-28 | ||||||
| 2021-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $8.24M derived: sum of 2 quarters · filed 2022-11-08 | $6.85M 10-Q · filed 2022-11-08 | -$861.53K 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | $238.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.15M 10-Q · filed 2022-08-09 | -$678.24K 10-Q · filed 2021-08-11 | |||||||
| 2021-03-31 | -$1.38M 10-Q · filed 2022-05-10 | -$413.58K 10-Q · filed 2021-06-03 | ||||||||
| 2020-12-31 | -$247.86K 10-K/A · filed 2021-11-24 | -$10.65M 10-K · filed 2022-03-15 | ||||||||
| 2020-09-30 | -$2.06K 10-Q/A · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |